News

2022 Jun 03

2022 Biomedical Business Plan Challenge Showcases Promising Startups

A promising venture that hopes to develop a new drug therapy for colorectal cancer won $50,000 in funding and recognition from experienced venture capitalists on May 26 at the annual Biomedical Business Plan Challenge. The... Read more

3D rendering of a NK Cell (Natural Killer Cell) destroying a cancer cell

2022 Jun 02

Immune Therapy Targets Cells that Cause Leukemia Relapse

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the... Read more

2022 May 31

Awards and Honors – May 31, 2022

Dr. Joseph J. Fins , chief of the Division of Medical Ethics, the E. William Davis Jr., M.D., Professor of Medical Ethics and a professor of medicine, was honored as an Honorary Doctor of Humane Letters at Wesleyan... Read more

2022 May 27

New Cancer Subtype May Illuminate Treatment Strategy

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its... Read more

2022 May 25

Study Reveals Cause, Potential Precision Therapies for Aggressive Type of Lymphoma

DNA mutations are essential to the rapid development of an array of antibody-producing immune cells called B cells that collectively can recognize a vast number of specific targets. But this process can go awry in people... Read more

2022 May 15

Benefits of PSA Prostate Cancer Screening Found to Be More Favorable than Previous Estimates, Especially for Blacks

New research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve University found that prostate cancer screening with the prostate specific... Read more

2022 May 09

Tumor Release of Lactate Forces Nearby Cells into Supportive Role

Tumors can force neighboring cells into supporting cancer growth by releasing lactate into their local environment, according to researchers at Weill Cornell Medicine. The findings pave the way for future drug treatments... Read more

2022 May 09

T Cell Behavior Determines Which Tumors Respond to Treatment

Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn’t work, and new research may help explain why. When immune cells called T lymphocytes infiltrate... Read more

2022 May 04

Advance in Understanding Cell Division Could Lead to New Cancer Treatments

A protein called CDC7, long thought to play an essential role early in the cell division process, is in fact replaceable by another protein called CDK1, according to a study by investigators at Weill Cornell Medicine and the... Read more

a doctor giving results to a patient who is out of the shot

2022 Apr 22

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate... Read more

2022 Apr 13

Tumors Change Their Metabolism to Spread More Effectively

Cancer cells can disrupt a metabolic pathway that breaks down fats and proteins to boost the levels of a byproduct called methylmalonic acid, thereby driving metastasis, according to research led by scientists at Weill... Read more

2022 Mar 16

A Potential New Target for Cancer Immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and... Read more

2022 Mar 10

New Collaborations Win Funding from Starr Cancer Consortium

Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium . Both grants will fund work applying new technologies to develop more detailed... Read more

2022 Mar 03

Three Weill Cornell Medicine Faculty Win ASCI Young Physician-Scientist Awards

Three Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation. The 2022 award recipients are Drs. Bishoy M. Faltas, Gunisha Kaur and Hasina... Read more

2022 Feb 18

Patient Possibly Cured of HIV Infection by Special Stem-Cell Transplant

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according... Read more

2022 Feb 11

Newly Funded New York City Center Aims to Reduce Health Disparities in Chronic Disease

A multi-institutional group in New York City has united to address health disparities in multiple chronic diseases through a new collaborative center. The vision of the Center to Improve Chronic Disease Outcomes through... Read more

2022 Jan 28

Researchers Identify Key Regulator of Blood Stem Cell Development

A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study from researchers at... Read more

Illustration of red and white blood cells. Credit: Shutterstock

2022 Jan 28

Researchers Identify Key Regulator of Blood Stem Cell Development

Illustration of red and white blood cells. Credit: Shutterstock A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood... Read more

2022 Jan 27

Partnership with Dr. Ari M. Melnick: New View of Lymph Nodes Shows Immune Cells in Real Time

Cornell researchers have for the first time successfully imaged the entire depth of the lymph nodes in a living mouse using three-photon microscopy. The breakthrough technique’s micrometer clarity and noninvasive nature... Read more

2022 Jan 19

Research Illuminates How Melanoma Readies Lymph Nodes for Tumor Spread

Melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases, according to a new study by Weill Cornell Medicine investigators... Read more

2022 Biomedical Business Plan Challenge Showcases Promising Startups

Immune Therapy Targets Cells that Cause Leukemia Relapse

Awards and Honors – May 31, 2022

New Cancer Subtype May Illuminate Treatment Strategy

Study Reveals Cause, Potential Precision Therapies for Aggressive Type of Lymphoma

Benefits of PSA Prostate Cancer Screening Found to Be More Favorable than Previous Estimates, Especially for Blacks

Tumor Release of Lactate Forces Nearby Cells into Supportive Role

T Cell Behavior Determines Which Tumors Respond to Treatment

Advance in Understanding Cell Division Could Lead to New Cancer Treatments

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases

Tumors Change Their Metabolism to Spread More Effectively

A Potential New Target for Cancer Immunotherapies

New Collaborations Win Funding from Starr Cancer Consortium

Three Weill Cornell Medicine Faculty Win ASCI Young Physician-Scientist Awards

Patient Possibly Cured of HIV Infection by Special Stem-Cell Transplant

Newly Funded New York City Center Aims to Reduce Health Disparities in Chronic Disease

Researchers Identify Key Regulator of Blood Stem Cell Development

Researchers Identify Key Regulator of Blood Stem Cell Development

Partnership with Dr. Ari M. Melnick: New View of Lymph Nodes Shows Immune Cells in Real Time

Research Illuminates How Melanoma Readies Lymph Nodes for Tumor Spread

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters